\relax 
\providecommand\hyper@newdestlabel[2]{}
\providecommand\HyperFirstAtBeginDocument{\AtBeginDocument}
\HyperFirstAtBeginDocument{\ifx\hyper@anchor\@undefined
\global\let\oldcontentsline\contentsline
\gdef\contentsline#1#2#3#4{\oldcontentsline{#1}{#2}{#3}}
\global\let\oldnewlabel\newlabel
\gdef\newlabel#1#2{\newlabelxx{#1}#2}
\gdef\newlabelxx#1#2#3#4#5#6{\oldnewlabel{#1}{{#2}{#3}}}
\AtEndDocument{\ifx\hyper@anchor\@undefined
\let\contentsline\oldcontentsline
\let\newlabel\oldnewlabel
\fi}
\fi}
\global\let\hyper@last\relax 
\gdef\HyperFirstAtBeginDocument#1{#1}
\providecommand\HyField@AuxAddToFields[1]{}
\providecommand\HyField@AuxAddToCoFields[2]{}
\providecommand \oddpage@label [2]{}
\babel@aux{english}{}
\@writefile{toc}{\contentsline {chapter}{\numberline {1}Transcription}{4}{chapter.1}\protected@file@percent }
\@writefile{lof}{\addvspace {10\p@ }}
\@writefile{lot}{\addvspace {10\p@ }}
\@writefile{loa}{\addvspace {10\p@ }}
\@writefile{toc}{\contentsline {section}{\numberline {1.1}Transcription initiation}{4}{section.1.1}\protected@file@percent }
\newlabel{transcription-initiation}{{1.1}{4}{Transcription initiation}{section.1.1}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {1.1}{\ignorespaces Sainsbury et al., Nature Review Mol. Cell. Biol. 2015\relax }}{4}{figure.caption.2}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {1.2}{\ignorespaces Sainsbury et al., Nature Review Mol. Cell. Biol. 2015\relax }}{5}{figure.caption.3}\protected@file@percent }
\@writefile{toc}{\contentsline {section}{\numberline {1.2}Chromatin remodeling}{6}{section.1.2}\protected@file@percent }
\newlabel{chromatin-remodeling}{{1.2}{6}{Chromatin remodeling}{section.1.2}{}}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {1.2.0.1}Techniques to study chromatin remodelling}{6}{subsubsection.1.2.0.1}\protected@file@percent }
\newlabel{techniques-to-study-chromatin-remodelling}{{1.2.0.1}{6}{Techniques to study chromatin remodelling}{subsubsection.1.2.0.1}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {1.3}{\ignorespaces Nucleosome occupancy\relax }}{7}{figure.caption.4}\protected@file@percent }
\providecommand*\caption@xref[2]{\@setref\relax\@undefined{#1}}
\newlabel{fig:nucleosome}{{1.3}{7}{Nucleosome occupancy\relax }{figure.caption.4}{}}
\@writefile{toc}{\contentsline {section}{\numberline {1.3}Nucleosome organization}{7}{section.1.3}\protected@file@percent }
\newlabel{nucleosome-organization}{{1.3}{7}{Nucleosome organization}{section.1.3}{}}
\@writefile{toc}{\contentsline {subsection}{\numberline {1.3.1}Nucleosome remodelling}{7}{subsection.1.3.1}\protected@file@percent }
\newlabel{nucleosome-remodelling}{{1.3.1}{7}{Nucleosome remodelling}{subsection.1.3.1}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {1.4}{\ignorespaces Becker and Workman, Cold Spring Harbor Laboratory, 2013\relax }}{8}{figure.caption.5}\protected@file@percent }
\newlabel{fig:peeling}{{1.4}{8}{Becker and Workman, Cold Spring Harbor Laboratory, 2013\relax }{figure.caption.5}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {1.5}{\ignorespaces Venkatesh and Workman, Nature Rev Mol Cell Biol, 2015\relax }}{8}{figure.caption.6}\protected@file@percent }
\newlabel{fig:pronucleo}{{1.5}{8}{Venkatesh and Workman, Nature Rev Mol Cell Biol, 2015\relax }{figure.caption.6}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {1.6}{\ignorespaces Cross linking\relax }}{9}{figure.caption.7}\protected@file@percent }
\@writefile{toc}{\contentsline {subsection}{\numberline {1.3.2}Chromatin Immunoprecipitation}{9}{subsection.1.3.2}\protected@file@percent }
\@writefile{toc}{\contentsline {subsection}{\numberline {1.3.3}Main nucleosome modifications in promoters:}{9}{subsection.1.3.3}\protected@file@percent }
\newlabel{main-nucleosome-modifications-in-promoters}{{1.3.3}{9}{Main nucleosome modifications in promoters:}{subsection.1.3.3}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {1.7}{\ignorespaces Guenther et al., Cell 2007\relax }}{10}{figure.caption.8}\protected@file@percent }
\@writefile{toc}{\contentsline {subsubsection}{\numberline {1.3.3.1}RT-qPCR based detection of 5' RNA transcripts of inactive genes}{10}{subsubsection.1.3.3.1}\protected@file@percent }
\newlabel{rt-qpcr-based-detection-of-5-rna-transcripts-of-inactive-genes}{{1.3.3.1}{10}{RT-qPCR based detection of 5' RNA transcripts of inactive genes}{subsubsection.1.3.3.1}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {1.8}{\ignorespaces Core et al, 2008\relax }}{11}{figure.caption.9}\protected@file@percent }
\@writefile{toc}{\contentsline {subsubsection}{\numberline {1.3.3.2}Global run-on sequencing (GRO-seq)}{11}{subsubsection.1.3.3.2}\protected@file@percent }
\newlabel{global-run-on-sequencing-gro-seq}{{1.3.3.2}{11}{Global run-on sequencing (GRO-seq)}{subsubsection.1.3.3.2}{}}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {1.3.3.3}Transcription pausing mechanism}{11}{subsubsection.1.3.3.3}\protected@file@percent }
\newlabel{transcription-pausing-mechanism}{{1.3.3.3}{11}{Transcription pausing mechanism}{subsubsection.1.3.3.3}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {1.9}{\ignorespaces Differential phosphorylation of RNA Pol II CTD during transcription.\relax }}{12}{figure.caption.10}\protected@file@percent }
\newlabel{fig:phCTD}{{1.9}{12}{Differential phosphorylation of RNA Pol II CTD during transcription.\relax }{figure.caption.10}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {1.10}{\ignorespaces Jonkers \& Lis, Nature Rev Mol Cell Biol, 2015\relax }}{12}{figure.caption.11}\protected@file@percent }
\newlabel{fig:dsif}{{1.10}{12}{Jonkers \& Lis, Nature Rev Mol Cell Biol, 2015\relax }{figure.caption.11}{}}
\@writefile{toc}{\contentsline {section}{\numberline {1.4}Transcription elongation}{13}{section.1.4}\protected@file@percent }
\@writefile{toc}{\contentsline {subsection}{\numberline {1.4.1}Structural basis of the nucleosome transition during RNA pol II passage - Kujirai et al 2018}{13}{subsection.1.4.1}\protected@file@percent }
\newlabel{structural-basis-of-the-nucleosome-transition-during-rna-pol-ii-passage---kujirai-et-al-2018}{{1.4.1}{13}{Structural basis of the nucleosome transition during RNA pol II passage - Kujirai et al 2018}{subsection.1.4.1}{}}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {1.4.1.1}Nucleosome structure}{13}{subsubsection.1.4.1.1}\protected@file@percent }
\newlabel{nucleosome-structure}{{1.4.1.1}{13}{Nucleosome structure}{subsubsection.1.4.1.1}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {1.11}{\ignorespaces Kujirai and Kurumizaka, \emph  {Curr Op. Struct. Biol.,} 2020\relax }}{14}{figure.caption.12}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {1.12}{\ignorespaces Screenshot 2022-10-05 at 22.57.06.png\relax }}{14}{figure.caption.13}\protected@file@percent }
\@writefile{toc}{\contentsline {subsubsection}{\numberline {1.4.1.2}Cryo-EM}{14}{subsubsection.1.4.1.2}\protected@file@percent }
\newlabel{cryo-em}{{1.4.1.2}{14}{Cryo-EM}{subsubsection.1.4.1.2}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {1.13}{\ignorespaces Kujirai at al., \emph  {Science,} 2018\relax }}{14}{figure.caption.14}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {1.14}{\ignorespaces Screenshot 2022-10-05 at 23.02.04.png\relax }}{15}{figure.caption.15}\protected@file@percent }
\@writefile{toc}{\contentsline {subsubsection}{\numberline {1.4.1.3}Summary of the main results}{15}{subsubsection.1.4.1.3}\protected@file@percent }
\newlabel{summary-of-the-main-results}{{1.4.1.3}{15}{Summary of the main results}{subsubsection.1.4.1.3}{}}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {1.4.1.4}Template looping}{15}{subsubsection.1.4.1.4}\protected@file@percent }
\newlabel{template-looping}{{1.4.1.4}{15}{Template looping}{subsubsection.1.4.1.4}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {1.15}{\ignorespaces Kujirai and Kurumizaka., \emph  {Curr Op. Struct. Biol.,} 2020 Template looping results in histone transfer from ahead of the transcribing RNApol II to behind\relax }}{16}{figure.caption.16}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {1.16}{\ignorespaces Lai and Pugh, \emph  {Nature Review Mol Cell Biol}. 2017\relax }}{16}{figure.caption.17}\protected@file@percent }
\@writefile{toc}{\contentsline {subsubsection}{\numberline {1.4.1.5}Structural basis of nucleosome disassembly and reassembly by RNA P II elongation complex with FACT - Ehara et al.}{16}{subsubsection.1.4.1.5}\protected@file@percent }
\newlabel{structural-basis-of-nucleosome-disassembly-and-reassembly-by-rna-p-ii-elongation-complex-with-fact---ehara-et-al.}{{1.4.1.5}{16}{Structural basis of nucleosome disassembly and reassembly by RNA P II elongation complex with FACT - Ehara et al}{subsubsection.1.4.1.5}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {1.17}{\ignorespaces Van Oss \emph  {et al., TRENDS Biochem Sci.} 2017\relax }}{16}{figure.caption.18}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {1.18}{\ignorespaces Screenshot 2022-10-10 at 10.35.12.png\relax }}{17}{figure.caption.19}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {1.19}{\ignorespaces Porrua \& Libri, Nature Review Mol Cell Biol, 2015\relax }}{17}{figure.caption.20}\protected@file@percent }
\@writefile{toc}{\contentsline {section}{\numberline {1.5}Transcription termination}{17}{section.1.5}\protected@file@percent }
\newlabel{termination}{{1.5}{17}{Transcription termination}{section.1.5}{}}
\@writefile{toc}{\contentsline {subsection}{\numberline {1.5.1}Promoter reporter assay}{17}{subsection.1.5.1}\protected@file@percent }
\newlabel{promoter-reporter-assay}{{1.5.1}{17}{Promoter reporter assay}{subsection.1.5.1}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {1.20}{\ignorespaces Anderson \& Sandelin, \emph  {Nature Review Gen}. 2019\relax }}{18}{figure.caption.21}\protected@file@percent }
\@writefile{toc}{\contentsline {subsection}{\numberline {1.5.2}Promoter types}{18}{subsection.1.5.2}\protected@file@percent }
\newlabel{promoter-types}{{1.5.2}{18}{Promoter types}{subsection.1.5.2}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {1.21}{\ignorespaces Lenhard \emph  {et al., Nature Rev Cancer} 2012\relax }}{19}{figure.caption.22}\protected@file@percent }
\@writefile{toc}{\contentsline {subsection}{\numberline {1.5.3}Transcription factor binding}{19}{subsection.1.5.3}\protected@file@percent }
\newlabel{transcription-factor-binding}{{1.5.3}{19}{Transcription factor binding}{subsection.1.5.3}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {1.22}{\ignorespaces Haberle \& Stark, \emph  {NatRevMolCelBiol.} 2018\relax }}{20}{figure.caption.23}\protected@file@percent }
\@writefile{toc}{\contentsline {chapter}{\numberline {2}Transcription regulation and its deregulation in cancer}{21}{chapter.2}\protected@file@percent }
\@writefile{lof}{\addvspace {10\p@ }}
\@writefile{lot}{\addvspace {10\p@ }}
\@writefile{loa}{\addvspace {10\p@ }}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {2.0.0.1}Mediator complex}{21}{subsubsection.2.0.0.1}\protected@file@percent }
\newlabel{mediator-complex}{{2.0.0.1}{21}{Mediator complex}{subsubsection.2.0.0.1}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {2.1}{\ignorespaces Screenshot 2022-10-07 at 10.47.50.png\relax }}{21}{figure.caption.24}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {2.2}{\ignorespaces Screenshot 2022-10-07 at 10.50.30.png\relax }}{22}{figure.caption.25}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {2.3}{\ignorespaces Soutourina\emph  {, Nature Review Mol Cell Biol.} 2018\relax }}{22}{figure.caption.26}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {2.4}{\ignorespaces Allen and Taatjes, \emph  {Nature Reviews Mol Cell Biol}. 2015\relax }}{23}{figure.caption.27}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {2.5}{\ignorespaces Bugter \emph  {et al., Nature Review Cancer}, 2021\relax }}{23}{figure.caption.28}\protected@file@percent }
\@writefile{toc}{\contentsline {subsection}{\numberline {2.0.1}Wnt signalling pathway}{23}{subsection.2.0.1}\protected@file@percent }
\newlabel{wnt-signalling-pathway}{{2.0.1}{23}{Wnt signalling pathway}{subsection.2.0.1}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {2.6}{\ignorespaces Screenshot 2022-10-10 at 11.04.14.png\relax }}{24}{figure.caption.29}\protected@file@percent }
\@writefile{toc}{\contentsline {subsubsection}{\numberline {2.0.1.1}$\beta $ -catenin structure}{24}{subsubsection.2.0.1.1}\protected@file@percent }
\newlabel{ux3b2-catenin-structure}{{2.0.1.1}{24}{$\beta $ -catenin structure}{subsubsection.2.0.1.1}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {2.7}{\ignorespaces Valenta \emph  {et al., EMBO J.} 2012\relax }}{25}{figure.caption.30}\protected@file@percent }
\@writefile{toc}{\contentsline {subsubsection}{\numberline {2.0.1.2}\textbf  {The canonical Wnt/$\beta $ -catenin pathway is crucially involved in colorectal cancer}}{25}{subsubsection.2.0.1.2}\protected@file@percent }
\newlabel{the-canonical-wntux3b2-catenin-pathway-is-crucially-involved-in-colorectal-cancer}{{2.0.1.2}{25}{\texorpdfstring {\textbf {The canonical Wnt/$\beta $ -catenin pathway is crucially involved in colorectal cancer}}{The canonical Wnt/$\beta $ -catenin pathway is crucially involved in colorectal cancer}}{subsubsection.2.0.1.2}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {2.8}{\ignorespaces McDonald \emph  {et al., Dev Cell}, 2009\relax }}{26}{figure.caption.31}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {2.9}{\ignorespaces Firestein \emph  {et al., Nature} 2008\relax }}{26}{figure.caption.32}\protected@file@percent }
\@writefile{toc}{\contentsline {section}{\numberline {2.1}6- Transcriptional Control in Cancer}{27}{section.2.1}\protected@file@percent }
\newlabel{transcriptional-control-in-cancer}{{2.1}{27}{6- Transcriptional Control in Cancer}{section.2.1}{}}
\@writefile{toc}{\contentsline {section}{\numberline {2.2}CREP/p300}{27}{section.2.2}\protected@file@percent }
\newlabel{crepp300}{{2.2}{27}{CREP/p300}{section.2.2}{}}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {2.2.0.1}CREP/p300 structure}{27}{subsubsection.2.2.0.1}\protected@file@percent }
\newlabel{crepp300-structure}{{2.2.0.1}{27}{CREP/p300 structure}{subsubsection.2.2.0.1}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {2.10}{\ignorespaces Wang \emph  {et al., Cell Mol Life Sci.} 2013\relax }}{28}{figure.caption.33}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {2.11}{\ignorespaces Screenshot 2022-10-12 at 09.01.27.png\relax }}{28}{figure.caption.34}\protected@file@percent }
\@writefile{toc}{\contentsline {subsection}{\numberline {2.2.1}\textbf  {TSSa-RNAs transcription}}{29}{subsection.2.2.1}\protected@file@percent }
\newlabel{tssa-rnas-transcription}{{2.2.1}{29}{\texorpdfstring {\textbf {TSSa-RNAs transcription}}{TSSa-RNAs transcription}}{subsection.2.2.1}{}}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {2.2.1.1}Properties of eRNAs}{30}{subsubsection.2.2.1.1}\protected@file@percent }
\newlabel{properties-of-ernas}{{2.2.1.1}{30}{Properties of eRNAs}{subsubsection.2.2.1.1}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {2.12}{\ignorespaces Studniarek \emph  {et al., Trends in Genetics,} 2021\relax }}{31}{figure.caption.35}\protected@file@percent }
\@writefile{toc}{\contentsline {subsubsection}{\numberline {2.2.1.2}\textbf  {Assessing whether the CRC 8q24 risk region acts as an enhancer}}{31}{subsubsection.2.2.1.2}\protected@file@percent }
\newlabel{assessing-whether-the-crc-8q24-risk-region-acts-as-an-enhancer}{{2.2.1.2}{31}{\texorpdfstring {\textbf {Assessing whether the CRC 8q24 risk region acts as an enhancer}}{Assessing whether the CRC 8q24 risk region acts as an enhancer}}{subsubsection.2.2.1.2}{}}
\@writefile{toc}{\contentsline {chapter}{\numberline {3}Chromsome domains and oncogene activation}{33}{chapter.3}\protected@file@percent }
\@writefile{lof}{\addvspace {10\p@ }}
\@writefile{lot}{\addvspace {10\p@ }}
\@writefile{loa}{\addvspace {10\p@ }}
\@writefile{toc}{\contentsline {section}{\numberline {3.1}7- Transcriptional Control in Cancer}{33}{section.3.1}\protected@file@percent }
\newlabel{transcriptional-control-in-cancer}{{3.1}{33}{7- Transcriptional Control in Cancer}{section.3.1}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {3.1}{\ignorespaces Screenshot 2022-10-14 at 10.52.51.png\relax }}{33}{figure.caption.36}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {3.2}{\ignorespaces Screenshot 2022-10-14 at 10.54.02.png\relax }}{34}{figure.caption.37}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {3.3}{\ignorespaces Screenshot 2022-10-14 at 11.20.37.png\relax }}{36}{figure.caption.38}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {3.4}{\ignorespaces Screenshot 2022-10-14 at 19.51.43.png\relax }}{37}{figure.caption.39}\protected@file@percent }
\@writefile{toc}{\contentsline {subsubsection}{\numberline {3.1.0.1}Cohesin mediates transcriptional insulation by CCCTC-binding factor}{37}{subsubsection.3.1.0.1}\protected@file@percent }
\newlabel{cohesin-mediates-transcriptional-insulation-by-ccctc-binding-factor}{{3.1.0.1}{37}{Cohesin mediates transcriptional insulation by CCCTC-binding factor}{subsubsection.3.1.0.1}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {3.5}{\ignorespaces Screenshot 2022-10-14 at 19.50.44.png\relax }}{38}{figure.caption.40}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {3.6}{\ignorespaces Herold \emph  {et al., Development,} 2012\relax }}{38}{figure.caption.41}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {3.7}{\ignorespaces Screenshot 2022-10-14 at 12.10.46.png\relax }}{38}{figure.caption.42}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {3.8}{\ignorespaces Screenshot 2022-10-14 at 19.52.56.png\relax }}{39}{figure.caption.43}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {3.9}{\ignorespaces Screenshot 2022-10-19 at 08.48.41.png\relax }}{40}{figure.caption.44}\protected@file@percent }
\@writefile{toc}{\contentsline {subsubsection}{\numberline {3.1.0.2}Chromosome Conformation Capture (3C)}{40}{subsubsection.3.1.0.2}\protected@file@percent }
\newlabel{chromosome-conformation-capture-3c}{{3.1.0.2}{40}{Chromosome Conformation Capture (3C)}{subsubsection.3.1.0.2}{}}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {3.1.0.3}Hi-C approach}{40}{subsubsection.3.1.0.3}\protected@file@percent }
\newlabel{hi-c-approach}{{3.1.0.3}{40}{Hi-C approach}{subsubsection.3.1.0.3}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {3.10}{\ignorespaces Lieberma-Aiden \emph  {et al., Science} 2009\relax }}{41}{figure.caption.45}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {3.11}{\ignorespaces Lieberma-Aiden \emph  {et al., Science} 2009\relax }}{41}{figure.caption.46}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {3.12}{\ignorespaces Screenshot 2022-10-19 at 09.10.50.png\relax }}{42}{figure.caption.47}\protected@file@percent }
\@writefile{toc}{\contentsline {subsubsection}{\numberline {3.1.0.4}Optimization of Hi-C approach}{42}{subsubsection.3.1.0.4}\protected@file@percent }
\newlabel{optimization-of-hi-c-approach}{{3.1.0.4}{42}{Optimization of Hi-C approach}{subsubsection.3.1.0.4}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {3.13}{\ignorespaces Screenshot 2022-10-19 at 09.11.30.png\relax }}{43}{figure.caption.48}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {3.14}{\ignorespaces Rowley and Corces, \emph  {Nature Rev Genetics} 2018\relax }}{44}{figure.caption.49}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {3.15}{\ignorespaces Dixon \emph  {et al., Mol Cell.} 2016\relax }}{44}{figure.caption.50}\protected@file@percent }
\@writefile{toc}{\contentsline {subsubsection}{\numberline {3.1.0.5}Promoter-Enhancer Communication Occurs Primarily within Insulated neighbourhoods}{45}{subsubsection.3.1.0.5}\protected@file@percent }
\newlabel{promoter-enhancer-communication-occurs-primarily-within-insulated-neighbourhoods}{{3.1.0.5}{45}{Promoter-Enhancer Communication Occurs Primarily within Insulated neighbourhoods}{subsubsection.3.1.0.5}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {3.16}{\ignorespaces Sun et al., 2019\relax }}{46}{figure.caption.51}\protected@file@percent }
\@writefile{toc}{\contentsline {subsection}{\numberline {3.1.1}Super-enhancers}{51}{subsection.3.1.1}\protected@file@percent }
\newlabel{super-enhancers}{{3.1.1}{51}{Super-enhancers}{subsection.3.1.1}{}}
\@writefile{toc}{\contentsline {section}{\numberline {3.2}How is a SE generated during tumorigenesis?}{52}{section.3.2}\protected@file@percent }
\newlabel{how-is-a-se-generated-during-tumorigenesis}{{3.2}{52}{How is a SE generated during tumorigenesis?}{section.3.2}{}}
\@writefile{toc}{\contentsline {subsection}{\numberline {3.2.1}How cancer cells take advantage of super-enhancers}{54}{subsection.3.2.1}\protected@file@percent }
\newlabel{how-cancer-cells-take-advantage-of-super-enhancers}{{3.2.1}{54}{How cancer cells take advantage of super-enhancers}{subsection.3.2.1}{}}
\@writefile{toc}{\contentsline {section}{\numberline {3.3}The role of MYC in cancer cells}{55}{section.3.3}\protected@file@percent }
\newlabel{the-role-of-myc-in-cancer-cells}{{3.3}{55}{The role of MYC in cancer cells}{section.3.3}{}}
\@writefile{toc}{\contentsline {subsection}{\numberline {3.3.1}Key aspect of MYC in tumorigenesis}{56}{subsection.3.3.1}\protected@file@percent }
\newlabel{key-aspect-of-myc-in-tumorigenesis}{{3.3.1}{56}{Key aspect of MYC in tumorigenesis}{subsection.3.3.1}{}}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {3.3.1.1}MYC transcription factor forms a heterodimer with MAX}{56}{subsubsection.3.3.1.1}\protected@file@percent }
\newlabel{myc-transcription-factor-forms-a-heterodimer-with-max}{{3.3.1.1}{56}{MYC transcription factor forms a heterodimer with MAX}{subsubsection.3.3.1.1}{}}
\@writefile{toc}{\contentsline {subsection}{\numberline {3.3.2}By which major mechanism or pathway MYC proteins promote tumorigenesis?}{57}{subsection.3.3.2}\protected@file@percent }
\newlabel{by-which-major-mechanism-or-pathway-myc-proteins-promote-tumorigenesis}{{3.3.2}{57}{By which major mechanism or pathway MYC proteins promote tumorigenesis?}{subsection.3.3.2}{}}
\@writefile{toc}{\contentsline {chapter}{\numberline {4}Targeting transcription in cancer}{59}{chapter.4}\protected@file@percent }
\@writefile{lof}{\addvspace {10\p@ }}
\@writefile{lot}{\addvspace {10\p@ }}
\@writefile{loa}{\addvspace {10\p@ }}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {4.0.0.1}Age-related remodellling of \textbf  {oesophageal epithelia by mutated cancer drivers}}{59}{subsubsection.4.0.0.1}\protected@file@percent }
\newlabel{age-related-remodellling-of-oesophageal-epithelia-by-mutated-cancer-drivers}{{4.0.0.1}{59}{\texorpdfstring {Age-related remodellling of \textbf {oesophageal epithelia by mutated cancer drivers}}{Age-related remodellling of oesophageal epithelia by mutated cancer drivers}}{subsubsection.4.0.0.1}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {4.1}{\ignorespaces Yokoyama et al., Nature 2019\relax }}{59}{figure.caption.52}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {4.2}{\ignorespaces Yokoyama et al., Nature 2019\relax }}{60}{figure.caption.53}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {4.3}{\ignorespaces Yokoyama et al., Nature 2019\relax }}{60}{figure.caption.54}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {4.4}{\ignorespaces Screen Shot 2022-11-04 at 11.25.54.png\relax }}{62}{figure.caption.55}\protected@file@percent }
\@writefile{toc}{\contentsline {subsubsection}{\numberline {4.0.0.2}Key points}{62}{subsubsection.4.0.0.2}\protected@file@percent }
\newlabel{key-points}{{4.0.0.2}{62}{Key points}{subsubsection.4.0.0.2}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {4.5}{\ignorespaces Gonda and Ramsay, \emph  {Nature Review Mol Cell Biology}, 2015\relax }}{63}{figure.caption.56}\protected@file@percent }
\@writefile{toc}{\contentsline {subsection}{\numberline {4.0.1}Target transcription in cancer}{63}{subsection.4.0.1}\protected@file@percent }
\newlabel{target-transcription-in-cancer}{{4.0.1}{63}{Target transcription in cancer}{subsection.4.0.1}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {4.6}{\ignorespaces Bywater \emph  {et al., Nature Review Cancer-} 2013\relax }}{64}{figure.caption.57}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {4.7}{\ignorespaces Screen Shot 2022-11-13 at 19-35-28.png\relax }}{65}{figure.caption.58}\protected@file@percent }
\@writefile{toc}{\contentsline {section}{\numberline {4.1}15- Transcriptional Control in Cancer}{65}{section.4.1}\protected@file@percent }
\newlabel{transcriptional-control-in-cancer}{{4.1}{65}{15- Transcriptional Control in Cancer}{section.4.1}{}}
\@writefile{toc}{\contentsline {section}{\numberline {4.2}BRD4}{65}{section.4.2}\protected@file@percent }
\newlabel{brd4}{{4.2}{65}{BRD4}{section.4.2}{}}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {4.2.0.1}Selective inhibition of Tumor Oncogenes by Disruption of Super-Enhancers}{65}{subsubsection.4.2.0.1}\protected@file@percent }
\newlabel{selective-inhibition-of-tumor-oncogenes-by-disruption-of-super-enhancers}{{4.2.0.1}{65}{Selective inhibition of Tumor Oncogenes by Disruption of Super-Enhancers}{subsubsection.4.2.0.1}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {4.8}{\ignorespaces Screen Shot 2022-11-13 at 19-40-17.png\relax }}{66}{figure.caption.59}\protected@file@percent }
\@writefile{toc}{\contentsline {section}{\numberline {4.3}YAP/TAZ}{66}{section.4.3}\protected@file@percent }
\newlabel{yaptaz}{{4.3}{66}{YAP/TAZ}{section.4.3}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {4.9}{\ignorespaces Screen Shot 2022-11-13 at 19-41-35.png\relax }}{67}{figure.caption.60}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {4.10}{\ignorespaces Dupont et al., Nature 2011\relax }}{67}{figure.caption.61}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {4.11}{\ignorespaces Screen Shot 2022-11-13 at 19-48-01.png\relax }}{68}{figure.caption.62}\protected@file@percent }
\@writefile{toc}{\contentsline {section}{\numberline {4.4}TEAD}{68}{section.4.4}\protected@file@percent }
\newlabel{tead}{{4.4}{68}{TEAD}{section.4.4}{}}
\@writefile{toc}{\contentsline {subsection}{\numberline {4.4.1}YAP/TAZ/TEAD}{68}{subsection.4.4.1}\protected@file@percent }
\newlabel{yaptaztead}{{4.4.1}{68}{YAP/TAZ/TEAD}{subsection.4.4.1}{}}
\@writefile{toc}{\contentsline {section}{\numberline {4.5}17- Transcriptional Control in Cancer}{69}{section.4.5}\protected@file@percent }
\newlabel{transcriptional-control-in-cancer}{{4.5}{69}{17- Transcriptional Control in Cancer}{section.4.5}{}}
\@writefile{toc}{\contentsline {section}{\numberline {4.6}Nuclear receptors}{69}{section.4.6}\protected@file@percent }
\newlabel{nuclear-receptors}{{4.6}{69}{Nuclear receptors}{section.4.6}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {4.12}{\ignorespaces Screen Shot 2022-11-18 at 11-11-12.png\relax }}{70}{figure.caption.63}\protected@file@percent }
\@writefile{toc}{\contentsline {subsection}{\numberline {4.6.1}Estrogen receptor \(\alpha \)}{70}{subsection.4.6.1}\protected@file@percent }
\newlabel{estrogen-receptor-alpha}{{4.6.1}{70}{\texorpdfstring {Estrogen receptor \(\alpha \)}{Estrogen receptor \textbackslash alpha}}{subsection.4.6.1}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {4.13}{\ignorespaces Screen Shot 2022-11-18 at 11-06-54.png\relax }}{71}{figure.caption.64}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {4.14}{\ignorespaces Screen Shot 2022-11-18 at 11-14-09.png\relax }}{71}{figure.caption.65}\protected@file@percent }
\@writefile{toc}{\contentsline {subsection}{\numberline {4.6.2}ER$\alpha $) in breast cancer}{71}{subsection.4.6.2}\protected@file@percent }
\@writefile{toc}{\contentsline {subsubsection}{\numberline {4.6.2.1}Mechanisms provoking breast cancer drug resistance}{72}{subsubsection.4.6.2.1}\protected@file@percent }
\newlabel{mechanisms-provoking-breast-cancer-drug-resistance}{{4.6.2.1}{72}{Mechanisms provoking breast cancer drug resistance}{subsubsection.4.6.2.1}{}}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {4.6.2.2}Summary}{72}{subsubsection.4.6.2.2}\protected@file@percent }
\newlabel{summary}{{4.6.2.2}{72}{Summary}{subsubsection.4.6.2.2}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {4.15}{\ignorespaces Screen Shot 2022-11-18 at 11-59-02.png\relax }}{73}{figure.caption.66}\protected@file@percent }
\@writefile{toc}{\contentsline {subsubsection}{\numberline {4.6.2.3}ER$\alpha $ transcriptional program}{73}{subsubsection.4.6.2.3}\protected@file@percent }
\newlabel{ertranscriptional-program}{{4.6.2.3}{73}{\texorpdfstring {ER$\alpha $ transcriptional program}{ERtranscriptional program}}{subsubsection.4.6.2.3}{}}
\@writefile{toc}{\contentsline {chapter}{\numberline {5}Transcription and genome instability}{75}{chapter.5}\protected@file@percent }
\@writefile{lof}{\addvspace {10\p@ }}
\@writefile{lot}{\addvspace {10\p@ }}
\@writefile{loa}{\addvspace {10\p@ }}
\@writefile{toc}{\contentsline {subsection}{\numberline {5.0.1}R-loops}{75}{subsection.5.0.1}\protected@file@percent }
\newlabel{r-loops}{{5.0.1}{75}{R-loops}{subsection.5.0.1}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {5.1}{\ignorespaces Hamperl and Cimprich, DNA Repair, 2014\relax }}{75}{figure.caption.67}\protected@file@percent }
\@writefile{toc}{\contentsline {subsubsection}{\numberline {5.0.1.1}R-loop degradation}{76}{subsubsection.5.0.1.1}\protected@file@percent }
\newlabel{r-loop-degradation}{{5.0.1.1}{76}{R-loop degradation}{subsubsection.5.0.1.1}{}}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {5.0.1.2}R-loop recognition and distribution}{76}{subsubsection.5.0.1.2}\protected@file@percent }
\newlabel{r-loop-recognition-and-distribution}{{5.0.1.2}{76}{R-loop recognition and distribution}{subsubsection.5.0.1.2}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {5.2}{\ignorespaces Screen Shot 2022-11-23 at 10-18-00.png\relax }}{77}{figure.caption.68}\protected@file@percent }
\@writefile{toc}{\contentsline {subsubsection}{\numberline {5.0.1.3}VIM-antisense1}{77}{subsubsection.5.0.1.3}\protected@file@percent }
\newlabel{vim-antisense1}{{5.0.1.3}{77}{VIM-antisense1}{subsubsection.5.0.1.3}{}}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {5.0.1.4}Main findings}{77}{subsubsection.5.0.1.4}\protected@file@percent }
\newlabel{main-findings}{{5.0.1.4}{77}{Main findings}{subsubsection.5.0.1.4}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {5.3}{\ignorespaces Screen Shot 2022-11-25 at 11-49-03.png\relax }}{78}{figure.caption.69}\protected@file@percent }
\@writefile{toc}{\contentsline {subsection}{\numberline {5.0.2}HOTTIP-dependent R-loop formation regulates CTCF boundary activity and TAD integrity in leukemia}{78}{subsection.5.0.2}\protected@file@percent }
\newlabel{hottip-dependent-r-loop-formation-regulates-ctcf-boundary-activity-and-tad-integrity-in-leukemia}{{5.0.2}{78}{HOTTIP-dependent R-loop formation regulates CTCF boundary activity and TAD integrity in leukemia}{subsection.5.0.2}{}}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {5.0.2.1}Conclusions}{79}{subsubsection.5.0.2.1}\protected@file@percent }
\newlabel{conclusions}{{5.0.2.1}{79}{Conclusions}{subsubsection.5.0.2.1}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {5.4}{\ignorespaces Base excision repair\relax }}{80}{figure.caption.70}\protected@file@percent }
\@writefile{toc}{\contentsline {subsection}{\numberline {5.0.3}HOTTIP lncRNA Promotes Hematopoietic Stem Cells Self-Renewal Leading to AML-like Disease in Mice}{80}{subsection.5.0.3}\protected@file@percent }
\newlabel{hottip-lncrna-promotes-hematopoietic-stem-cells-self-renewal-leading-to-aml-like-disease-in-mice}{{5.0.3}{80}{HOTTIP lncRNA Promotes Hematopoietic Stem Cells Self-Renewal Leading to AML-like Disease in Mice}{subsection.5.0.3}{}}
\@writefile{toc}{\contentsline {section}{\numberline {5.1}20- Transcriptional Control in Cancer}{80}{section.5.1}\protected@file@percent }
\newlabel{transcriptional-control-in-cancer}{{5.1}{80}{20- Transcriptional Control in Cancer}{section.5.1}{}}
\@writefile{toc}{\contentsline {section}{\numberline {5.2}Transcription and genome instability II}{80}{section.5.2}\protected@file@percent }
\newlabel{transcription-and-genome-instability-ii}{{5.2}{80}{Transcription and genome instability II}{section.5.2}{}}
\@writefile{toc}{\contentsline {subsection}{\numberline {5.2.1}DNA damage}{80}{subsection.5.2.1}\protected@file@percent }
\newlabel{dna-damage}{{5.2.1}{80}{DNA damage}{subsection.5.2.1}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {5.5}{\ignorespaces R loop repair\relax }}{81}{figure.caption.71}\protected@file@percent }
\@writefile{toc}{\contentsline {subsubsection}{\numberline {5.2.1.1}R loop modified bases}{81}{subsubsection.5.2.1.1}\protected@file@percent }
\newlabel{r-loop-modified-bases}{{5.2.1.1}{81}{R loop modified bases}{subsubsection.5.2.1.1}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {5.6}{\ignorespaces Apical kinases\relax }}{82}{figure.caption.72}\protected@file@percent }
\@writefile{toc}{\contentsline {subsection}{\numberline {5.2.2}Apical kinases}{82}{subsection.5.2.2}\protected@file@percent }
\newlabel{apical-kinases}{{5.2.2}{82}{Apical kinases}{subsection.5.2.2}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {5.7}{\ignorespaces Blackford and Jackson, \emph  {Mol Cell}, 2017\relax }}{83}{figure.caption.73}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {5.8}{\ignorespaces Trenner and Satori, Frontiers in Oncology 2019\relax }}{83}{figure.caption.74}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {5.9}{\ignorespaces Screen Shot 2022-11-30 at 10-03-17.png\relax }}{84}{figure.caption.75}\protected@file@percent }
\@writefile{toc}{\contentsline {subsection}{\numberline {5.2.3}Topoisomerases}{84}{subsection.5.2.3}\protected@file@percent }
\newlabel{topoisomerases}{{5.2.3}{84}{Topoisomerases}{subsection.5.2.3}{}}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {5.2.3.1}A topoisomerase IIb-mediated dsDNA break required for Regulated Transcription}{84}{subsubsection.5.2.3.1}\protected@file@percent }
\newlabel{a-topoisomerase-iib-mediated-dsdna-break-required-for-regulated-transcription}{{5.2.3.1}{84}{A topoisomerase IIb-mediated dsDNA break required for Regulated Transcription}{subsubsection.5.2.3.1}{}}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {5.2.3.2}BRCA1}{85}{subsubsection.5.2.3.2}\protected@file@percent }
\newlabel{brca1}{{5.2.3.2}{85}{BRCA1}{subsubsection.5.2.3.2}{}}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {5.2.3.3}Stark et al.}{85}{subsubsection.5.2.3.3}\protected@file@percent }
\newlabel{stark-et-al.}{{5.2.3.3}{85}{Stark et al}{subsubsection.5.2.3.3}{}}
\@writefile{toc}{\contentsline {chapter}{\numberline {6}Role of transcription in DNA damage response and repair}{87}{chapter.6}\protected@file@percent }
\@writefile{lof}{\addvspace {10\p@ }}
\@writefile{lot}{\addvspace {10\p@ }}
\@writefile{loa}{\addvspace {10\p@ }}
\@writefile{toc}{\contentsline {subsection}{\numberline {6.0.1}Biogenesis of canonical miRNA}{87}{subsection.6.0.1}\protected@file@percent }
\newlabel{biogenesis-of-canonical-mirna}{{6.0.1}{87}{Biogenesis of canonical miRNA}{subsection.6.0.1}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {6.1}{\ignorespaces Francia \emph  {et al., Nature} 2012\relax }}{88}{figure.caption.76}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {6.2}{\ignorespaces Francia \emph  {et al., Nature} 2012\relax }}{88}{figure.caption.77}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {6.3}{\ignorespaces Francia \emph  {et al., Nature} 2012\relax }}{89}{figure.caption.78}\protected@file@percent }
\@writefile{toc}{\contentsline {subsection}{\numberline {6.0.2}DICER and DROSH regulation of DDR and checkpoint enforcement}{89}{subsection.6.0.2}\protected@file@percent }
\newlabel{dicer-and-drosh-regulation-of-ddr-and-checkpoint-enforcement}{{6.0.2}{89}{DICER and DROSH regulation of DDR and checkpoint enforcement}{subsection.6.0.2}{}}
\@writefile{toc}{\contentsline {subsection}{\numberline {6.0.3}DDRNAs}{89}{subsection.6.0.3}\protected@file@percent }
\newlabel{ddrnas}{{6.0.3}{89}{DDRNAs}{subsection.6.0.3}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {6.4}{\ignorespaces Michelini \emph  {et al., Nature Cell Biology} 2017\relax }}{90}{figure.caption.79}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {6.5}{\ignorespaces Michelini \emph  {et al., Nature Cell Biology} 2017\relax }}{90}{figure.caption.80}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {6.6}{\ignorespaces Michelini \emph  {et al., Nature Cell Biology} 2017\relax }}{91}{figure.caption.81}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {6.7}{\ignorespaces Michelini \emph  {et al., Nature Cell Biology} 2017\relax }}{91}{figure.caption.82}\protected@file@percent }
\@writefile{toc}{\contentsline {subsubsection}{\numberline {6.0.3.1}DDRNAs and dilncRNAs regulate DDR and DNA repair}{91}{subsubsection.6.0.3.1}\protected@file@percent }
\newlabel{ddrnas-and-dilncrnas-regulate-ddr-and-dna-repair}{{6.0.3.1}{91}{DDRNAs and dilncRNAs regulate DDR and DNA repair}{subsubsection.6.0.3.1}{}}
\@writefile{toc}{\contentsline {subsection}{\numberline {6.0.4}RNA Pol II recruitment at DSBs}{92}{subsection.6.0.4}\protected@file@percent }
\newlabel{rna-pol-ii-recruitment-at-dsbs}{{6.0.4}{92}{RNA Pol II recruitment at DSBs}{subsection.6.0.4}{}}
\@writefile{toc}{\contentsline {chapter}{\numberline {7}Telomeres and telomere transcription in cancer}{93}{chapter.7}\protected@file@percent }
\@writefile{lof}{\addvspace {10\p@ }}
\@writefile{lot}{\addvspace {10\p@ }}
\@writefile{loa}{\addvspace {10\p@ }}
\@writefile{toc}{\contentsline {subsection}{\numberline {7.0.1}What are telomeres?}{93}{subsection.7.0.1}\protected@file@percent }
\newlabel{what-are-telomeres}{{7.0.1}{93}{What are telomeres?}{subsection.7.0.1}{}}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {7.0.1.1}Telomeres mask chromosome ends from being recognized as double-strand breaks}{93}{subsubsection.7.0.1.1}\protected@file@percent }
\newlabel{telomeres-mask-chromosome-ends-from-being-recognized-as-double-strand-breaks}{{7.0.1.1}{93}{Telomeres mask chromosome ends from being recognized as double-strand breaks}{subsubsection.7.0.1.1}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {7.1}{\ignorespaces Lim and Cech, Nature Reviews Mol Cell Biol, 2021\relax }}{94}{figure.caption.83}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {7.2}{\ignorespaces Cesare \emph  {et al., Mol Cell} 2013\relax }}{94}{figure.caption.84}\protected@file@percent }
\@writefile{toc}{\contentsline {subsection}{\numberline {7.0.2}Telomere dysfunction in a p53 and Rb mutant setting does not induce cell cycle block}{94}{subsection.7.0.2}\protected@file@percent }
\newlabel{telomere-dysfunction-in-a-p53-and-rb-mutant-setting-does-not-induce-cell-cycle-block}{{7.0.2}{94}{Telomere dysfunction in a p53 and Rb mutant setting does not induce cell cycle block}{subsection.7.0.2}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {7.3}{\ignorespaces Screen Shot 2022-12-15 at 17-49-51.png\relax }}{95}{figure.caption.85}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {7.4}{\ignorespaces Doksani \& de Lange. \emph  {Cold Spring Harbor Press.} 2014 Nature Reviews Cancer, 2008\relax }}{95}{figure.caption.86}\protected@file@percent }
\@writefile{toc}{\contentsline {subsection}{\numberline {7.0.3}End of replication problem}{95}{subsection.7.0.3}\protected@file@percent }
\newlabel{end-of-replication-problem}{{7.0.3}{95}{End of replication problem}{subsection.7.0.3}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {7.5}{\ignorespaces Screen Shot 2022-12-15 at 18-00-30.png\relax }}{96}{figure.caption.87}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {7.6}{\ignorespaces Stewart \& Weinberg. Ann Rev Cell Dev Biol, 2006\relax }}{97}{figure.caption.88}\protected@file@percent }
\@writefile{toc}{\contentsline {subsubsection}{\numberline {7.0.3.1}Hayflick limit}{97}{subsubsection.7.0.3.1}\protected@file@percent }
\newlabel{hayflick-limit}{{7.0.3.1}{97}{Hayflick limit}{subsubsection.7.0.3.1}{}}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {7.0.3.2}Triggering senescence}{97}{subsubsection.7.0.3.2}\protected@file@percent }
\newlabel{triggering-senescence}{{7.0.3.2}{97}{Triggering senescence}{subsubsection.7.0.3.2}{}}
\@writefile{toc}{\contentsline {subsection}{\numberline {7.0.4}Cell crisis}{98}{subsection.7.0.4}\protected@file@percent }
\newlabel{cell-crisis}{{7.0.4}{98}{Cell crisis}{subsection.7.0.4}{}}
\@writefile{toc}{\contentsline {subsection}{\numberline {7.0.5}Telomerase enzyme}{98}{subsection.7.0.5}\protected@file@percent }
\newlabel{telomerase-enzyme}{{7.0.5}{98}{Telomerase enzyme}{subsection.7.0.5}{}}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {7.0.5.1}Usage of telomerase}{98}{subsubsection.7.0.5.1}\protected@file@percent }
\newlabel{usage-of-telomerase}{{7.0.5.1}{98}{Usage of telomerase}{subsubsection.7.0.5.1}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {7.7}{\ignorespaces Screen Shot 2022-12-15 at 22-58-03.png\relax }}{99}{figure.caption.89}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {7.8}{\ignorespaces Screen Shot 2022-12-15 at 22-58-28.png\relax }}{99}{figure.caption.90}\protected@file@percent }
\@writefile{toc}{\contentsline {chapter}{\numberline {8}Journal Clubs}{101}{chapter.8}\protected@file@percent }
\@writefile{lof}{\addvspace {10\p@ }}
\@writefile{lot}{\addvspace {10\p@ }}
\@writefile{loa}{\addvspace {10\p@ }}
\@writefile{toc}{\contentsline {section}{\numberline {8.1}11- JC Transcriptional Control in Cancer}{101}{section.8.1}\protected@file@percent }
\@writefile{toc}{\contentsline {subsection}{\numberline {8.1.1}MYC Recruits SPT5 to RNA Polymerase II to Promote Processive Transcription Elongation}{101}{subsection.8.1.1}\protected@file@percent }
\newlabel{myc-recruits-spt5-to-rna-polymerase-ii-to-promote-processive-transcription-elongation}{{8.1.1}{101}{MYC Recruits SPT5 to RNA Polymerase II to Promote Processive Transcription Elongation}{subsection.8.1.1}{}}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {8.1.1.1}Tet-Off/On transgenic system:}{101}{subsubsection.8.1.1.1}\protected@file@percent }
\newlabel{tet-offon-transgenic-system}{{8.1.1.1}{101}{Tet-Off/On transgenic system:}{subsubsection.8.1.1.1}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {8.1}{\ignorespaces Screenshot 2022-10-28 at 10.37.23.png\relax }}{102}{figure.caption.91}\protected@file@percent }
\@writefile{toc}{\contentsline {subsubsection}{\numberline {8.1.1.2}MYC Controls the Assembly of Transcriptionally Engaged Pol II Complexes}{102}{subsubsection.8.1.1.2}\protected@file@percent }
\newlabel{myc-controls-the-assembly-of-transcriptionally-engaged-pol-ii-complexes}{{8.1.1.2}{102}{MYC Controls the Assembly of Transcriptionally Engaged Pol II Complexes}{subsubsection.8.1.1.2}{}}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {8.1.1.3}CDK7 Activity is Required for Transfer of SPT5 from MYC to Pol II}{102}{subsubsection.8.1.1.3}\protected@file@percent }
\newlabel{cdk7-activity-is-required-for-transfer-of-spt5-from-myc-to-pol-ii}{{8.1.1.3}{102}{CDK7 Activity is Required for Transfer of SPT5 from MYC to Pol II}{subsubsection.8.1.1.3}{}}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {8.1.1.4}MYC Influences Processivity and Directionality of Pol II after pause release}{102}{subsubsection.8.1.1.4}\protected@file@percent }
\newlabel{myc-influences-processivity-and-directionality-of-pol-ii-after-pause-release}{{8.1.1.4}{102}{MYC Influences Processivity and Directionality of Pol II after pause release}{subsubsection.8.1.1.4}{}}
\@writefile{toc}{\contentsline {subsection}{\numberline {8.1.2}BRD4-directed super-enhancer organization of transcription repression programs links to chemotherapeutic efficacy in breast cancer}{103}{subsection.8.1.2}\protected@file@percent }
\newlabel{brd4-directed-super-enhancer-organization-of-transcription-repression-programs-links-to-chemotherapeutic-efficacy-in-breast-cancer}{{8.1.2}{103}{BRD4-directed super-enhancer organization of transcription repression programs links to chemotherapeutic efficacy in breast cancer}{subsection.8.1.2}{}}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {8.1.2.1}BRD4 is physically associated with LSD1/NuRD complex}{103}{subsubsection.8.1.2.1}\protected@file@percent }
\newlabel{brd4-is-physically-associated-with-lsd1nurd-complex}{{8.1.2.1}{103}{BRD4 is physically associated with LSD1/NuRD complex}{subsubsection.8.1.2.1}{}}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {8.1.2.2}BRD4 and the LSD1/NuRD complex occupy SE}{103}{subsubsection.8.1.2.2}\protected@file@percent }
\newlabel{brd4-and-the-lsd1nurd-complex-occupy-se}{{8.1.2.2}{103}{BRD4 and the LSD1/NuRD complex occupy SE}{subsubsection.8.1.2.2}{}}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {8.1.2.3}Decommissioning the BRD4/LSD1/NuRD Complex Leads to JQ1 Resistance}{103}{subsubsection.8.1.2.3}\protected@file@percent }
\newlabel{decommissioning-the-brd4lsd1nurd-complex-leads-to-jq1-resistance}{{8.1.2.3}{103}{Decommissioning the BRD4/LSD1/NuRD Complex Leads to JQ1 Resistance}{subsubsection.8.1.2.3}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {8.2}{\ignorespaces Screenshot 2022-10-28 at 11.55.04.png\relax }}{104}{figure.caption.92}\protected@file@percent }
\@writefile{toc}{\contentsline {subsubsection}{\numberline {8.1.2.4}Elimination of PELI1 Improves the Therapeutic Efficacy of JQ1 in Breast Cancer Cells}{104}{subsubsection.8.1.2.4}\protected@file@percent }
\newlabel{elimination-of-peli1-improves-the-therapeutic-efficacy-of-jq1-in-breast-cancer-cells}{{8.1.2.4}{104}{Elimination of PELI1 Improves the Therapeutic Efficacy of JQ1 in Breast Cancer Cells}{subsubsection.8.1.2.4}{}}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {8.1.2.5}The Clinicopathological Significance of the PELI1-LSD1-BRD4/LSD1/ NuRD Axis in Breast Cancer}{104}{subsubsection.8.1.2.5}\protected@file@percent }
\newlabel{the-clinicopathological-significance-of-the-peli1-lsd1-brd4lsd1-nurd-axis-in-breast-cancer}{{8.1.2.5}{104}{The Clinicopathological Significance of the PELI1-LSD1-BRD4/LSD1/ NuRD Axis in Breast Cancer}{subsubsection.8.1.2.5}{}}
